AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπΌ
DAPAGLIFLOZIN in Zimbabwe
12 products registered with MCAZ β 12 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NONE TABLET, COATED; ORAL | 2026/17.7/7402 | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | 20 Apr 2031 |
| SKY PHARM DAPA 5MG TABLET, COATED; ORAL | 2025/17.7/6968 | ADVENTURA INVESTMENTS LTD | active | 23 May 2030 |
| DAPAGLIFLOZIN 10 COSPHARM TABLET, COATED; ORAL | 2025/17.7/6868 | COSPHARM INVESTMESTS PVT LTD | active | 13 Feb 2030 |
| DAPAGLIFLOZIN 5 COSPHARM TABLET, COATED; ORAL | 2025/17.7/6867 | COSPHARM INVESTMENTS PVT LTD | active | 13 Feb 2030 |
| GLYDA 5 TABLET, COATED; ORAL | 2025/17.7/6824 | HETERO LABS LTD | active | 16 Jan 2030 |
| GLYDA 10 TABLET, COATED; ORAL | 2025/17.7/6825 | HETERO LABS LTD | active | 16 Jan 2030 |
| SKY PHARMA DAPA 10MG TABLET, COATED; ORAL | 2025/17.7/6810 | ADVENTURA INVESTMENTS LTD | active | 10 Jan 2030 |
| DEXIGLOFOZIN TABLET, COATED; ORAL | 2024/17.7/6670 | ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIES | active | 18 Jul 2029 |
| AVAXIGA 5 TABLET, COATED; ORAL | 2024/17.7/6730 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| DAPAONE 10 TABLET, COATED; ORAL | 2024/17.7/6661 | MSN LABORATORIES LTD | active | 31 Dec 2027 |
| AVAXIGA 10 TABLET, COATED; ORAL | 2024/17.7/6731 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
| DAPAONE 5 TABLET, COATED; ORAL | 2024/17.7/6660 | MSN LABORATORIES PRIVATE LIMITED | active | 31 Dec 2027 |
DAPAGLIFLOZIN β MCAZ Registration Details
MCAZ (Zimbabwe) has 12 registered products containing DAPAGLIFLOZIN, of which 12 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DAPAGLIFLOZIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.